Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration
| Status: | Recruiting |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 8/23/2018 |
| Start Date: | April 2015 |
| End Date: | December 2021 |
| Contact: | Theodore Leng, MD |
| Phone: | 650-723-6995 |
The investigators have developed an image analysis method that can predict the likelihood
that a patient with age related macular degeneration (AMD) will progress within 1 year, based
on computerized analysis of optical coherence tomography (OCT) images that are routinely
acquired in clinical practice on each patient visit to the ophthalmologist. The
investigators' goal is to evaluate whether this method will improve the ability to detect AMD
earlier and improve visual outcomes in AMD patients by assigning patient risk categories and
having patients come back for follow up based on those categories.
that a patient with age related macular degeneration (AMD) will progress within 1 year, based
on computerized analysis of optical coherence tomography (OCT) images that are routinely
acquired in clinical practice on each patient visit to the ophthalmologist. The
investigators' goal is to evaluate whether this method will improve the ability to detect AMD
earlier and improve visual outcomes in AMD patients by assigning patient risk categories and
having patients come back for follow up based on those categories.
Inclusion Criteria:
- Non-exudative age-related macular degeneration
Exclusion Criteria:
- Exudative age-related macular degeneration
We found this trial at
1
site
Palo Alto, California 94303
Principal Investigator: Theodore Leng, MD
Phone: 650-723-6995
Click here to add this to my saved trials
